CRISPR-CAS3 SYSTEMS FOR TARGETED GENOME ENGINEERING
Abstract:
The present disclosure provides systems and methods of altering a nucleic acid sequence, which comprise an engineered Type I CRISPR/Cas system comprising Cas3 and Cas11. Particularly. the system and methods described herein use compact engineered CRISPR-Cas3 systems (e.g., Type I-C, Type I-B, or Type I-D) for genetic manipulations (e.g., in eukaryotic cells).
Information query
Patent Agency Ranking
0/0